Skip to main content

ENvue Medical, Inc.

FEED
Exchange
OTC
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001326706

No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by ENvue Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for ENvue Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for ENvue Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Glibert Christian MichaelOther: No longer subject to section 10Jun 22, 20263
Bank Of America Corp10% Owner231,138IndirectFeb 4, 20261
Bank Of America NA10% Owner231,138IndirectFeb 4, 20261
Bofa Securities, Inc.10% Owner231,138IndirectFeb 4, 20261
Murphy Brian MChief Executive Officer–Jan 3, 20250
Brown Stephen RussellChief Financial Officer4,000Jan 2, 20250
Mika ThomasDirector50,000Jan 2, 20250
Fashek Christopher MDirector75,000Jan 2, 20250
Jacob HaroldChief Medical Officer–Jan 2, 20250
Ferguson MichaelDirector–Jan 2, 20250
Goldstein Martin MDirector–Jan 2, 20250
Cassirer AuroraDirector2,000Jan 2, 20250
Schroeder MariaDirector–Jan 2, 20250

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 22, 2026 (view filing)Jun 22Same dayGlibert Christian MichaelOther: No longer subject to section 1SSale−210.0K$0.69−$144.9K−100.0%0 after
Feb 11, 2026 (view filing)Jan 1428 daysLateGlibert Christian Michael10% OwnerPPurchaseCommon Stock, par value $0.001 per share+240.0K$2.67+$640.8KNew position240.0K after
Feb 4, 2026 (view filing)9:03 PM ETFeb 22 daysBank Of America Corp and 2 others10% OwnerSSale−2.92K$3.05−$8.91K−1.2%231.1K after30 lots
Jan 5, 2023 (view filing)4:05 PM ETJan 5Same dayMika ThomasDirectorPPurchase+50.0K$0.25+$12.5KNew position50.0K after
Jun 17, 2022 (view filing)Jun 152 daysFashek Christopher MDirectorPPurchase+40.0K$0.60+$24.0K+114.3%75.0K after
Jun 17, 2022 (view filing)Nov 20, 2019940 daysLateFashek Christopher MDirectorPPurchase+25.0K$2.00+$50.0KNew position25.0K after
Jun 14, 2022 (view filing)Jun 14Same dayBrown Stephen RussellChief Financial OfficerPPurchase+4.00K$0.57+$2.28KNew position4.00K after
Jun 2, 2022 (view filing)Jun 11 dayCassirer AuroraDirectorPPurchase+2.00K$0.69+$1.38KNew position2.00K after